0001104659-23-120737.txt : 20231226 0001104659-23-120737.hdr.sgml : 20231226 20231122160543 ACCESSION NUMBER: 0001104659-23-120737 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 CORRESP 1 filename1.htm

Immunome, Inc.

665 Stockton Drive, Suite 300

Exton, PA 19341

November 22, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Tamika N. Sheppard

Re:

Immunome, Inc.

Registration Statement on Form S-3

File No. 333-275598

Acceleration Request

Requested Date:

November 27, 2023

Requested Time:

4:00 PM Eastern Time

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Immunome, Inc. hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-275598) (the “Registration Statement”) to become effective on November 27, 2023, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.

Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez at Cooley LLP at (858) 550-6157 or Dylan Kornbluth of Cooley LLP at (858) 550-6173. Thank you for your assistance with this matter.

	Very truly yours,

	Immunome, Inc.


	By:	/s/ Sandra Stoneman
		Sandra Stoneman
		Chief Legal Officer

cc:

Thomas Coll, Cooley LLP

Carlos Ramirez, Cooley LLP

Dylan Kornbluth, Cooley LLP